Gene · 6362
Papers4,584
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,584
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lactate activates CCL18 expression via H3K18 lactylation in macrophages to promote tumorigenesis of ovarian cancer. | Acta Biochim Biophys Sin (Shanghai) | 2024 | 39010846 | PubTator, text mining | PubMed |
| MMP9 and CCL18 associate with chronic urticaria while type I, IV, and VI collagens change with omalizumab treatment. | Allergy | 2024 | 38953463 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis of macrophage subpopulations contributing to chemotherapy resistance in ovarian cancer. | Immunobiology | 2024 | 38941863 | PubTator, text mining | PubMed |
| Effects of Active Chronic Cigarette-Smoke Exposure on Circulating Fibrocytes. | Lung | 2024 | 38935158 | PubTator, text mining | PubMed |
| Bidirectional Two-Sample Mendelian Randomization Study of Immunoglobulin G N-Glycosylation and Senescence-Associated Secretory Phenotype. | Int J Mol Sci | 2024 | 38928043 | PubTator, text mining | PubMed |
| CHIT1 at diagnosis predicts faster disability progression and reflects early microglial activation in multiple sclerosis. | Nat Commun | 2024 | 38866782 | PubTator, text mining | PubMed |
| Epidermal growth factor receptor/mitogen-activated kinase inhibitor treatment induces a distinct inflammatory hair follicle response that includes collapse of immune privilege. | Br J Dermatol | 2024 | 38857906 | PubTator, text mining | PubMed |
| LncRNA CRNDE promotes hepatoma cell proliferation by regulating the metabolic reprogramming of M2 macrophages via ERK pathway. | Cancer Cell Int | 2024 | 38822362 | PubTator, text mining | PubMed |
| CCL18 aggravates atherosclerosis by inducing CCR6-dependent T-cell influx and polarization. | Front Immunol | 2024 | 38807599 | PubTator, text mining | PubMed |
| ACE Phenotyping in Human Blood and Tissues: Revelation of ACE Outliers and Sex Differences in ACE Sialylation. | Biomedicines | 2024 | 38790902 | PubTator, text mining | PubMed |
| The Immune Microenvironment Landscape of Pituitary NeuroEndocrine Tumors, a Transcriptomic Approach. | Genes (Basel) | 2024 | 38790160 | PubTator, text mining | PubMed |
| Analysis of prognostic value of lactate metabolism-related genes in ovarian cancer based on bioinformatics. | J Ovarian Res | 2024 | 38778371 | PubTator, text mining | PubMed |
| Pursuing Clinical Predictors and Biomarkers for Progression in ILD: Analysis of the Pulmonary Fibrosis Foundation (PFF) Registry. | Lung | 2024 | 38753183 | PubTator, text mining | PubMed |
| Enhancing pathological complete response prediction in breast cancer: the role of dynamic characterization of DCE-MRI and its association with tumor heterogeneity. | Breast Cancer Res | 2024 | 38745321 | PubTator, text mining | PubMed |
| Single-Cell Profiling Reveals Immune Aberrations in Progressive Idiopathic Pulmonary Fibrosis. | Am J Respir Crit Care Med | 2024 | 38717443 | PubTator, text mining | PubMed |
| Corrigendum to "CCL18-induced HOTAIR upregulation promotes malignant progression in esophageal squamous cell carcinoma through the miR-130a-5p-ZEB1 axis" [Cancer Lett. 460 (2019) 18-28]. | Cancer Lett | 2024 | 38702269 | PubTator, text mining | PubMed |
| Can Biomarkers and PET Imaging Predict Abdominal Aortic Aneurysm Growth Rate? | J Clin Med | 2024 | 38673721 | PubTator, text mining | PubMed |
| The Expression and Secretion Profile of TRAP5 Isoforms in Gaucher Disease. | Cells | 2024 | 38667330 | PubTator, text mining | PubMed |
| [Retracted] Upregulation of microRNA‑181b inhibits CCL18‑induced breast cancer cell metastasis and invasion via the NF‑κB signaling pathway. | Oncol Lett | 2024 | 38659419 | PubTator, text mining | PubMed |
| Targeted plasma proteomic analysis uncovers a high-performance biomarker panel for early diagnosis of gastric cancer. | Clin Chim Acta | 2024 | 38631604 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6362/papers?page=12